QTTB: Q32 Bio Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 307.42
Enterprise Value ($M) 437.31
Book Value ($M) -71.48
Book Value / Share -5.99
Price / Book -4.30
NCAV ($M) -89.82
NCAV / Share -7.53
Price / NCAV -3.42

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.87
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.04
Current Ratio 2.04

Balance Sheet (mrq) ($M)
Current Assets 28.72
Assets 47.06
Liabilities 118.53
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue -6.65
Operating Income -48.26
Net Income -53.74
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -18.68
Cash from Investing -0.01
Cash from Financing 0.41

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-04 13D Acorn Bioventures, L.p. 6.70
04-01 13D Atlas Venture Fund X, L.P. 7.20
03-29 13G Carlyle Group Inc. 9.20
03-28 13D Orbimed Advisors Llc 18.90

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-12 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A (Amendment No. 1) (Mark one) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRA

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 1,584 13,508 11.73
2024-05-02 7,327 12,169 60.21
2024-05-01 2,288 3,409 67.12
2024-04-30 1,714 2,999 57.15

(click for more detail)

Similar Companies
PROC – Procaps Group S.A. PTGX – Protagonist Therapeutics, Inc.
PWUP – PowerUp Acquisition Corp. RANI – Rani Therapeutics Holdings, Inc.
RAPT – RAPT Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io